Posted on 11/18/19
BioCryst Pharmaceuticals Announces Pricing of Public Offering
BioCryst Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 37,931,035 shares of its common stock in a press release Wednesday.The gross proceeds from . . .
Posted on 11/18/19
Aerie Pharmaceuticals Acquires Avizorex Pharma
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with . . .
Posted on 11/14/19
Medfusion Announces the Creation of a New Stand-alone Company
Medfusion, a healthcare-based technology company, has announced the creation of a new stand-alone company, Greenlight Health Data Solutions, in a press release Wednesday.Greenlight Health will provide . . .
Posted on 11/14/19
Premier Forms Contigo Health
Premier Inc. announced the formation of new company, Contigo Health, in a press release Tuesday.Contigo Health is a “network of health systems collaborating with employers and . . .
Posted on 11/12/19
Fennec Posts Better than Expected Loss in Q3
Fennec Pharmaceuticals Inc. beat analyst estimates with a smaller-than-expected loss of $1.8 million for the third quarter of 2019, the company announced Tuesday. The average analyst . . .
Posted on 11/12/19
Syneos Health Announces Partnership with AiCure to Improve Clinical Trials
Syneos Health and AiCure announced a partnership to develop faster and smarter clinical trials Tuesday morning in a press release.The companies said this is the first . . .
Posted on 11/8/19
SQZ Biotech and AskBio Announce Research Collaboration
SQZ Biotechnologies (SQZ), and Asklepios BioPharmaceutical, Inc. (AskBio), announced a research collaboration to create tolerizing antigen carriers (TACs) containing AAV (adeno-associated virus) components to solve one . . .
Posted on 11/7/19
BioCryst Reports Q3 Loss
BioCryst Pharmaceuticals reported a third quarter loss of 34 cents per share, missing analysts’ estimates of 32 cents in a press release Wednesday.Third-quarter revenue also missed . . .
Posted on 11/6/19
Skanska to Build New UNC Hospitals Surgical Tower in Chapel Hill, NC
Global development and construction firm Skanska has announced it will construct the new UNC Hospitals’ Surgical Tower located in the center of the UNC Healthcare campus. . . .
Posted on 11/2/19
vTv Reports Better than Expected Q3 Loss
vTv Therapeutics, Inc. a biopharmaceutical company, reported results that just exceeded analysts’ estimates and updated on two studies in a press release Wednesday.The company reported an . . .
Posted on 10/22/19
Is Aerie Pharmaceuticals a Buy?
Aerie Pharmaceuticals (NASDAQ:AERI) thinks it has something special in its two commercialized drug products, which utilize a novel mechanism of action to relieve the underlying cause . . .
Posted on 10/21/19
HealthEC, LabCorp, and The New Jersey Primary Care Association Announce Strategic Collaboration
BURLINGTON, N.C. & EDISON, N.J. & HAMILTON, N.J.--(BUSINESS WIRE)--LabCorp® (NYSE:LH), a leading global life sciences company, HealthEC, LLC, a 2019 Best in KLAS provider of population . . .
Posted on 10/14/19
Syneos Health Wins Society for Clinical Research Sites Eagle Award for Third Consecutive Year
MORRISVILLE, N.C., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company was awarded the . . .
Posted on 10/10/19
Why Shares of Dova Pharmaceuticals Took Off in September
What happenedShares of drugmaker Dova Pharmaceuticals (NASDAQ:DOVA) rose by 86.5% in September, according to data provided by S&P Global Market Intelligence.This added to Dova's big gains . . .
Posted on 10/9/19
Leading U.S. Health Systems Win Rothman Index Awards for Outstanding Clinical and Financial Improvement
CHARLOTTE, N.C.--(BUSINESS WIRE)--PeraHealth has announced the 2019 Rothman Index Award winners, bestowing the honors on hospitals and individuals who have used the Rothman Index to improve . . .
Posted on 10/9/19
Why G1 Therapeutics Stock Plunged 37.2% in September
What happenedShares of G1 Therapeutics (NASDAQ:GTHX) fell 37.2% in September, according to data from S&P Global Market Intelligence, after investors reacted to trial data for some . . .
Posted on 10/8/19
Vast Therapeutics’ BIOC11 Designated as Qualified Infectious Disease Product
Vast Therapeutics, Inc. announced its drug candidate, BIOC11, was named a Qualified Infectious Disease Product by the U.S. Food and Drug Administration in a press release . . .
Posted on 10/1/19
Chimerix Announces Exclusive Global License Agreement with SymBio Pharmaceuticals for Brincidofovir
DURHAM, N.C., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful . . .
Posted on 9/30/19
Vertex and Ribometrix Establish Strategic Collaboration
BOSTON & DURHAM, N.C.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and RNA therapeutics developer Ribometrix, Inc. announced today that the companies have entered into a strategic collaboration to . . .
Posted on 9/30/19
Dova Pharmaceuticals to be Acquired by Swedish Orphan Biovitrum AB
Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) announced today it has entered into an agreement and plan of merger with Swedish Orphan Biovitrum AB (Sobi) (OM:SOBI).
Posted on 9/30/19
Is GlaxoSmithKline a Buy?
Over the past several years, British pharmaceutical giant GlaxoSmithKline (NYSE:GSK) has been struggling to compete against some of its peers in the big pharma space. Despite . . .
Posted on 9/27/19
Announces $7.8M Financing
Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, today announced $7.8 million in additional funding
Posted on 9/27/19
ARS Treatment Centers Opens Opioid Treatment Clinic in Danville
DANVILLE, Va. & GREENVILLE, S.C.--(BUSINESS WIRE)--ARS Treatment Centers, a category leader in Office-Based Opioid Treatment (OBOT), announced today that its new community clinic is now open . . .
Posted on 9/26/19
U.S. Government Buys More Doses of BioCryst Flu Treatment
BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services purchased an additional 10,000 doses of RAPIVAB, an approved antiviral influenza therapy.By the end . . .
Posted on 9/26/19
BioCryst Pharmaceuticals: Waiting For A Cash Infusion
SummaryShares of BioCryst are stuck around $3 per share since the stock plunged after the company reported phase 3 results of BCX7353 in HAE patients.The company's . . .
Charlotte Raleigh
